🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06957613
Recruiting Observational

The Prospective Segeberg Registry for Coronary Chronic Total Occlusions (CTO)

NCT06957613 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2017-07-01
Last updated
2025-05-04

Condition(s) studied

Coronary Chronic Total Occlusions

Investigational drug(s) / intervention(s)

Revascularization/Conservative management

Revascularization/Conservative management: Percutaneous Transluminal Angioplasty of Coronary Chronic Total Occlusions via Dedicated Drug Eluting Stents and/or Balloons.

Study summary

A Prospective Follow-up Assessment in Bad Segeberg with Patients undergoing Recanalization for Coronary Chronic Total Occlusion Lesion/s

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: * Patients with coronary chronic total occlusions undergoing recanalization via percutaneous coronary interventions Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Herzzentrum Segeberger Kliniken GmbH Bad Segeberg Schleswig-Holstein Recruiting

More Segeberger Kliniken GmbH trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06957613 on ClinicalTrials.gov ↗ ← All trials in Germany